Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
Gao P, Chu J, Chen X, Li L, Fan R (2021) Selenium alleviates mercury chloride-induced liver injury by regulating mitochondrial dynamics to inhibit the crosstalk between energy metabolism disorder and NF-B/NLRP3 inflammasome-mediated inflammation
The skin was not just appearing firmer from surface hydration or temporary film-forming effects
Lowering free radicals throughout the body
Emerging evidence suggests that ME/CFS, GWS, and FM are all characterized by disturbances in metabolic pathways, particularly those related to energy production, lipid metabolism, and oxidative stress
Fully accredited with Save Face, a national register of accredited practitioners who provide non-surgical cosmetic treatments
US$ 22.06
US$ 22.60
US$ 28.67
US$ 24.82
